View All Patents
EP2279254
NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
Filed
Apr 15, 2009
Technology
Chemistry · Pharmaceuticals +1
UPC cases
5
EPO proceedings
3
Ownership history
As recorded at the EPO. Transfers made after the opposition period are recorded in national registers and may be missing here.
Hover an owner to see their dates
- Arbutus Biopharma Corporationsince Feb 14, 2020
- Protiva Biotherapeutics Inc.Dec 31, 2010 – Feb 14, 2020
Abstract
The present invention provides novel, stable lipid particles comprising one or more active agents or therapeutic agents, methods of making the lipid particles, and methods of delivering and/or administering the lipid particles. More particularly, the present invention provides stable nucleic acid-lipid particles (SNALP) comprising a nucleic acid (such as one or more interfering RNA), methods of making the SNALP, and methods of delivering and/or administering the SNALP.
From the international application WO2009127060
Litigation history
| Date | Case | Division | Type | Outcome | Parties |
|---|---|---|---|---|---|
| Aug 25, 2026 | UPC CFI 191/2025 | The Hague LD | Infringement | Locked | Genevant Sciences GmbH +2 |
Additional proceedings on this patent
Start 14-day free trialOutcomes, the additional proceedings and the register history.Already a user? Sign in